Clinical Trial Update: A Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia [NA]

View source ↗

Summary

The trial updates the completion of a study evaluating a novel Valsalva assist device for terminating supraventricular tachycardia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Supraventricular Tachycardia

Drugs mentioned

• Novel Valsalva Assist Device for Terminating Supraventricular Tachycardia

Snippet

Sponsor: Beijing Anzhen Hospital | Conditions: Supraventricular Tachycardia (SVT) | NA | Status: COMPLETED